Search

Your search keyword '"Nocca D"' showing total 255 results
Start Over Author "Nocca D"
255 results on '"Nocca D"'

2. SOFFCO-MM guidelines for the resumption of bariatric and metabolic surgery during and after the Covid-19 pandemic

Author

Abittan, R., Abou-Mrad, A., Arnalsteen, L., Arnoux, R., Auguste, T., Benchetrit, S., Berthet, B., Bertrand, J.-C., Blanchard, L.-C., Bouillot, J.-L., Caiazzo, R., Catheline, J.-M., Chevallier, J.-M., Dargent, J., Fournier, P., Frering, V., Gugenheim, J., Johanet, H., Lechaux, D., Leyre, P., Liagre, A., Mouiel, J., Nocca, D., Pourcher, G., Reche, F., Robert, M., Sebbag, H., Sodji, M., Tuyeras, G., Zimmermann, J.-M., Kassir, R., Rebibo, L., Genser, L., Sterkers, A., Blanchet, M.-C., Pattou, F., and Msika, S.

Published
2020
Full Text
View/download PDF

3. Recommandations de la SOFFCO-MM en vue de la reprise de l’activité de chirurgie bariatrique et métabolique pendant et après la pandémie Covid-19

Author

Abittan, R., Abou-Mrad, A., Arnalsteen, L., Arnoux, R., Auguste, T., Benchetrit, S., Berthet, B., Bertrand, J.-C., Blanchard, L.-C., Bouillot, J.-L., Caiazzo, R., Catheline, J.-M., Chevallier, J.-M., Dargent, J., Fournier, P., Frering, V., Gugenheim, J., Johanet, H., Lechaux, D., Leyre, P., Liagre, A., Mouiel, J., Nocca, D., Pourcher, G., Reche, F., Robert, M., Sebbag, H., Sodji, M., Tuyeras, G., Zimmermann, J.-M., Kassir, R., Rebibo, L., Genser, L., Sterkers, A., Blanchet, M.-C., Pattou, F., and Msika, S.

Published
2020
Full Text
View/download PDF

4. Perioperative Interventions to Prevent Gastroesophageal Reflux Disease and Marginal Ulcers After Bariatric Surgery — an International Experts’ Survey

Author

Chiappetta, S., Stier, C., Ghanem, O. M., Dayyeh, B. K. A., Boskoski, Ivo, Prager, G., Lamasters, T., Kermansaravi, M., Aarts, E., Abbas, I., Angrisani, L., Antozzi, L., Asghar, T., Bashir, A., Behrens, E., Bhandari, M., Bhasker, A., Billy, H., Carbajo, M. -A., Chevallier, J. M., Cohen, R., Dargent, J., De Luca, M., de Moura, E., Dillemans, B., Di Lorenzo, N., Hayssam El Fawal, M., Moritz Felsenreich, D., Fishman, S., Gagner, M., Galvao, M., Gawdat, K., Gee, T., Ghavami, B., Haddad, A., Hanssen, A., Herrera, M. F., Higa, K., Himpens, J. M., Kasama, K., Kassir, R., Khan, A., Khidir, N., Khoursheed, M., Khwaja, H., Kow, L., Kroh, M., Singh Kular, K., Lainas, P., Lakdawala, M., Layani, L., Loi, K., Mahawar, K., Mahdy, T., Mala, T., Miller, K., Musella, Martina, Neymark, A., Nimeri, A., Nocca, D., Noel, P., Omarov, T., Palermo, M., Parmar, C., Pazouki, A., Poggi, L., Poghosyan, T., Pompa, L., Ponce, J., Pournaras, D., Prasad, A., Alqahtani, A., Ramos, A., Rezvani, M., Rheinwalt, K., Ribeiro, R., Rotundo, A., Ruiz-Ucar, E., Safadi, B., Sakran, N., Salminen, P., Schroeder, O., Seki, Y., Shabbir, A., Shahabi Shahmiri, S., Shikora, S., Stein, J., Stenberg, E., Taskin, E., Torres, A., Villalonga, R., Weiner, R., Weiner, S., Yang, W., Zehetner, J., Zundel, N., Boskoski I. (ORCID:0000-0001-8194-2670), Musella M., Chiappetta, S., Stier, C., Ghanem, O. M., Dayyeh, B. K. A., Boskoski, Ivo, Prager, G., Lamasters, T., Kermansaravi, M., Aarts, E., Abbas, I., Angrisani, L., Antozzi, L., Asghar, T., Bashir, A., Behrens, E., Bhandari, M., Bhasker, A., Billy, H., Carbajo, M. -A., Chevallier, J. M., Cohen, R., Dargent, J., De Luca, M., de Moura, E., Dillemans, B., Di Lorenzo, N., Hayssam El Fawal, M., Moritz Felsenreich, D., Fishman, S., Gagner, M., Galvao, M., Gawdat, K., Gee, T., Ghavami, B., Haddad, A., Hanssen, A., Herrera, M. F., Higa, K., Himpens, J. M., Kasama, K., Kassir, R., Khan, A., Khidir, N., Khoursheed, M., Khwaja, H., Kow, L., Kroh, M., Singh Kular, K., Lainas, P., Lakdawala, M., Layani, L., Loi, K., Mahawar, K., Mahdy, T., Mala, T., Miller, K., Musella, Martina, Neymark, A., Nimeri, A., Nocca, D., Noel, P., Omarov, T., Palermo, M., Parmar, C., Pazouki, A., Poggi, L., Poghosyan, T., Pompa, L., Ponce, J., Pournaras, D., Prasad, A., Alqahtani, A., Ramos, A., Rezvani, M., Rheinwalt, K., Ribeiro, R., Rotundo, A., Ruiz-Ucar, E., Safadi, B., Sakran, N., Salminen, P., Schroeder, O., Seki, Y., Shabbir, A., Shahabi Shahmiri, S., Shikora, S., Stein, J., Stenberg, E., Taskin, E., Torres, A., Villalonga, R., Weiner, R., Weiner, S., Yang, W., Zehetner, J., Zundel, N., Boskoski I. (ORCID:0000-0001-8194-2670), and Musella M.

Abstract

Objective: This study aimed to survey international experts in metabolic and bariatric surgery (MBS) to improve and consolidate perioperative interventions to prevent gastroesophageal reflux disease (GERD) and marginal ulcers (MU) after MBS. Background: Very important long-term complications after MBS include GERD, Barrett’s esophagus, and MU. Prevention might be fundamental to reduce the incidence, severe complications, and the increasing number of revisional bariatric surgeries. Methods: An international scientific team designed an online confidential questionnaire with 45 multiple-choice questions. The survey was sent to 110 invited experts and 96 of them (from 41 different countries) participated from 21 July 2022 to 4 September 2022. Results: Most experts (≥ 90%) prescribe postoperative acid suppression agents after MBS. Life-long proton pump inhibitors prophylaxis in smokers with avoidance of non-steroidal anti-inflammatory drugs are recommended by most of the experts (66%, 73%) after any type of gastric bypass. Two-thirds of experts (69%) perform Helicobacter pylori eradication prior to MBS. Two-thirds of experts (68%) routinely perform EGD and biopsy before MBS. Follow-up esophagogastroduodenoscopy (EGD) and timing threshold for revisional and conversional MBS were variable among experts. Conclusion: This expert survey underlines important perioperative interventions that reached a two-thirds consensus among MBS international experts. Variability in follow-up EGD, approach to complication management, and thresholds for revisional and conversional MBS emphasize the need for further researches and consensus guidelines. Graphical Abstract: [Figure not available: see fulltext.].

Published
2023

24. SOFFCO-MM guidelines for the resumption of bariatric and metabolic surgery during and after the Covid-19 pandemic

Author

Kassir, R., primary, Rebibo, L., additional, Genser, L., additional, Sterkers, A., additional, Blanchet, M.-C., additional, Pattou, F., additional, Msika, S., additional, Abittan, R., additional, Abou-Mrad, A., additional, Arnalsteen, L., additional, Arnoux, R., additional, Auguste, T., additional, Benchetrit, S., additional, Berthet, B., additional, Bertrand, J.-C., additional, Blanchard, L.-C., additional, Bouillot, J.-L., additional, Caiazzo, R., additional, Catheline, J.-M., additional, Chevallier, J.-M., additional, Dargent, J., additional, Fournier, P., additional, Frering, V., additional, Gugenheim, J., additional, Johanet, H., additional, Lechaux, D., additional, Leyre, P., additional, Liagre, A., additional, Mouiel, J., additional, Nocca, D., additional, Pourcher, G., additional, Reche, F., additional, Robert, M., additional, Sebbag, H., additional, Sodji, M., additional, Tuyeras, G., additional, and Zimmermann, J.-M., additional

Published
2020
Full Text
View/download PDF

25. Recommandations de la SOFFCO-MM en vue de la reprise de l’activité de chirurgie bariatrique et métabolique pendant et après la pandémie Covid-19

Author

Kassir, R., primary, Rebibo, L., additional, Genser, L., additional, Sterkers, A., additional, Blanchet, M.-C., additional, Pattou, F., additional, Msika, S., additional, Abittan, R., additional, Abou-Mrad, A., additional, Arnalsteen, L., additional, Arnoux, R., additional, Auguste, T., additional, Benchetrit, S., additional, Berthet, B., additional, Bertrand, J.-C., additional, Blanchard, L.-C., additional, Bouillot, J.-L., additional, Caiazzo, R., additional, Catheline, J.-M., additional, Chevallier, J.-M., additional, Dargent, J., additional, Fournier, P., additional, Frering, V., additional, Gugenheim, J., additional, Johanet, H., additional, Lechaux, D., additional, Leyre, P., additional, Liagre, A., additional, Mouiel, J., additional, Nocca, D., additional, Pourcher, G., additional, Reche, F., additional, Robert, M., additional, Sebbag, H., additional, Sodji, M., additional, Tuyeras, G., additional, and Zimmermann, J.-M., additional

Published
2020
Full Text
View/download PDF

38. Multicentre cohort study of antihypertensive and lipid‐lowering therapy cessation after bariatric surgery.

Author

Thereaux, J., Lesuffleur, T., Czernichow, S., Basdevant, A., Msika, S., Nocca, D., Millat, B., and Fagot‐Campagna, A.

Subjects
BARIATRIC surgery, GASTRIC bypass, COHORT analysis, NATIONAL health insurance, ODDS ratio
Abstract

Background: Few studies have assessed changes in antihypertensive and lipid‐lowering therapy after bariatric surgery. The aim of this study was to assess the 6‐year rates of continuation, discontinuation or initiation of antihypertensive and lipid‐lowering therapy after bariatric surgery compared with those in a matched control group of obese patients. Methods: This nationwide observational population‐based cohort study used data extracted from the French national health insurance database. All patients undergoing gastric bypass or sleeve gastrectomy in France in 2009 were matched with control patients. Mixed‐effect logistic regression models were used to analyse factors that influenced discontinuation or initiation of treatment over a 6‐year interval. Results: In 2009, 8199 patients underwent primary gastric bypass (55·2 per cent) or sleeve gastrectomy (44·8 per cent). After 6 years, the proportion of patients receiving antihypertensive and lipid‐lowering therapy had decreased more in the bariatric group than in the control group (antihypertensives: –40·7 versus –11·7 per cent respectively; lipid‐lowering therapy: –53·6 versus –20·2 per cent; both P < 0·001). Gastric bypass was the main predictive factor for discontinuation of therapy for hypertension (odds ratio (OR) 9·07, 95 per cent c.i. 7·72 to 10·65) and hyperlipidaemia (OR 11·91, 9·65 to 14·71). The proportion of patients not receiving treatment at baseline who were subsequently started on medication was lower after bariatric surgery than in controls for hypertension (5·6 versus 15·8 per cent respectively; P < 0·001) and hyperlipidaemia (2·2 versus 9·1 per cent; P < 0·001). Gastric bypass was the main protective factor for antihypertensives (OR 0·22, 0·18 to 0·26) and lipid‐lowering medication (OR 0·12, 0·09 to 0·15). Conclusion: Bariatric surgery is associated with a good discontinuation of antihypertensive and lipid‐lowering therapy, with gastric bypass being more effective than sleeve gastrectomy. Drugs often stopped [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

44. International Sleeve Gastrectomy Expert Panel Consensus Statement: best practice guidelines based on experience of >12,000 cases

Author

Rosenthal, Raul J., Diaz, A. A., Arvidsson, D., Baker, R. S., Basso, Nicola, Bellanger, D., Boza, C., El Mourad, H., France, M., Gagner, M., Galvao Neto, M., Higa, K. D., Himpens, J., Hutchinson, C. M., Jacobs, M., Jorgensen, J. O., Jossart, G., Lakdawala, M., Nguyen, N. T., Nocca, D., Prager, G., Pomp, A., Ramos, A. C., Rosenthal, R. J., Shah, S., Vix, M., Wittgrove, A., Zundel, N., and International Sleeve Gastrectomy Expert Panel

Subjects
Adult, Male, medicine.medical_specialty, Sleeve gastrectomy, Standardization, Statement (logic), Best practice, medicine.medical_treatment, MEDLINE, Postoperative Complications, Gastrectomy, Surveys and Questionnaires, Medicine, Humans, Practice Patterns, Physicians', Laparoscopic sleeve gastrectomy, Surgical approach, Evidence-Based Medicine, bariatric surgery, consensus statement, international sleeve gastrectomy expert panel, laparoscopic sleeve gastrectomy, morbid obesity, outcomes, business.industry, Evidence-based medicine, Middle Aged, Surgery, Practice Guidelines as Topic, Female, Laparoscopy, business
Abstract

Background: Laparoscopic sleeve gastrectomy (LSG) is an emerging surgical approach, but 1 that has seen a surge in popularity because of its perceived technical simplicity, feasibility, and good outcomes. An international expert panel was convened in Coral Gables, Florida on March 25 and 26, 2011, with the purpose of providing best practice guidelines through consensus regarding the performance of LSG. The panel comprised 24 centers and represented 11 countries, spanning all major regions of the world and all 6 populated continents, with a collective experience of 12,000 cases. It was thought prudent to hold an expert consensus meeting of some of the surgeons across the globe who have performed the largest volume of cases to discuss and provide consensus on the indications, contraindications, and procedural aspects of LSG. The panel undertook this consensus effort to help the surgical community improve the efficacy, lower the complication rates, and move toward adoption of standardized techniques and measures. The meeting took place at on-site meeting facilities, Biltmore Hotel, Coral Gables, Florida. Methods: Expert panelists were invited to participate according to their publications, knowledge and experience, and identification as surgeons who had performed 500 cases. The topics for consensus encompassed patient selection, contraindications, surgical technique, and the prevention and management of complications. The responses were calculated and defined as achieving con- sensus (70% agreement) or no consensus (70% agreement). Results: Full consensus was obtained for the essential aspects of the indications and contraindi- cations, surgical technique, management, and prevention of complications. Consensus was achieved for 69 key questions. Conclusion: The present consensus report represents the best practice guidelines for the perfor- mance of LSG, with recommendations in the 3 aforementioned areas. This report and its findings support a first effort toward the standardization of techniques and adoption of working recommen- dations formulated according to expert experience. (Surg Obes Relat Dis 2012;8:8-19.) © 2012 American Society for Metabolic and Bariatric Surgery. All rights reserved.

Published
2012

45. Resting energy expenditure and fuel metabolism following laparoscopic adjustable gastric banding in severely obese women: relationships with excess weight lost

Author

Barbotte E, Bringer J, Verdier R, J M Fabre, Renard E, F. Galtier, Nocca D, and Farret A

Subjects
Adult, medicine.medical_specialty, Adolescent, Gastroplasty, Endocrinology, Diabetes and Metabolism, Medicine (miscellaneous), Overweight, Lipid oxidation, Weight loss, Internal medicine, Weight Loss, medicine, Humans, Resting energy expenditure, Postoperative Period, Nutrition and Dietetics, medicine.diagnostic_test, Anthropometry, business.industry, Calorimetry, Indirect, Middle Aged, medicine.disease, Lipid Metabolism, Prognosis, Obesity, Obesity, Morbid, Respiratory quotient, Endocrinology, Treatment Outcome, Basal metabolic rate, Body Composition, Female, Basal Metabolism, medicine.symptom, Lipid profile, business, Energy Metabolism, Oxidation-Reduction, Follow-Up Studies
Abstract

Although adjustable gastric banding is increasingly proposed for massively obese patients, little is known about the modifications of resting metabolic rate and substrate oxidation or about metabolic determinants of weight loss following this type of bariatric surgery.To evaluate the relationships between excess weight loss, resting metabolic rate (RMR) and substrate oxidation, and to identify metabolic predictive factors of weight loss after adjustable gastric banding.Seventy-three obese nondiabetic women aged 39.1+/-10.4 years (18.4-64.8).Resting metabolic rate and substrate oxidation (indirect calorimetry), body composition (bio-impedance), lipid profile and insulin sensitivity indexes were assessed before and after (13.3+/-6.0 months, range 6.0-31.1) adjustable gastric banding. Patients were classified according to postsurgery time: group A (6-12 months, n=39); group B (12-18 months, n=21); group C (18 months, n=13). Metabolic parameters associated with the percentage of excess weight lost (EWL) 1 year after surgery were analyzed in univariate and multivariate regressions.Mean weight loss was 26.2+/-11.4 kg. Mean fat mass loss was 17.3+/-8.1 kg. All biological parameters associated with excess weight improved after surgery. Excess weight lost at 1 year was 45.9+/-17.1% in group A, 47.4+/-17.1% in group B and 51.4+/-18.5% in group C (P=NS). Resting metabolic rate/fat-free mass (FFM) slightly decreased (28.9+/-3.26 vs 30.3+/-2.8, P0.00001) and RMR/body weight slightly increased (18.5+/-2.8 vs 17.3+/-1.9, P0.00001) after surgery. Respiratory quotient (0.81+/-0.06 vs 0.82+/-0.05) and FFM-adjusted lipid oxidation (1.10+/-0.41 vs 1.05+/-0.33 mg/min/kg FFM) were not significantly modified after surgery. In multiple linear regression analysis, difference in RMR/body weight, difference in energy sparing, baseline BMI and postsurgery time, were significantly and independently correlated with EWL (total R2=72.5%).Adjustable gastric banding promotes gradual but sustained weight loss and is associated with long-term conservation of lipid oxidation and energy expenditure. The individual variability in energy sparing mechanisms predicts weight loss during the first year after surgery.

Published
2006

49. Traitement endoscopique des fistules post-sleeve gastrectomie: résultats d'une étude multicentrique, retrospective

Author

Christophorou, D, primary, Funakoshi, N, additional, Valats, JC, additional, Vedrenne, B, additional, Prat, F, additional, Bulois, P, additional, Branche, J, additional, Decoster, S, additional, Coron, E, additional, Duflos, C, additional, Picot, MC, additional, Nocca, D, additional, Bauret, P, additional, and Blanc, P, additional

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results